Day One Biopharmaceuticals, Inc. - DAWN

About Gravity Analytica
Recent News
- 03.04.2025 - 45th Annual TD Cowen Health Care Conference
- 02.25.2025 - Day One Biopharmaceuticals Q4 and Full Year 2024 Earnings Conference Call
- 02.25.2025 - Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress
- 02.11.2025 - Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025
- 01.27.2025 - Day One’s Next Chapter in Oncology Innovation
- 01.27.2025 - Day One’s Next Chapter in Oncology Innovation
Recent Filings
- 02.25.2025 - EX-99.1 EX-99.1
- 02.25.2025 - 8-K Current report
- 02.25.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
- 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
- 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
- 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
- 02.18.2025 - 144 Report of proposed sale of securities
- 02.18.2025 - 144 Report of proposed sale of securities
- 02.18.2025 - 144 Report of proposed sale of securities
- 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors